Methodological quality of the review: Medium confidence
Author: Zafar A, Khan GI, Siddiqui MAR.
Region: Details not provided
Sector: Diabetic retinopathy, screening, diagnostic accuracy studies (DAS), The Standards for Reporting of Diagnostic Accuracy (STARD).
Sub-sector: None specified
Equity focus: None specified
Review type: Effectiveness review
Quantitative synthesis method: Narrative analysis
Qualitative synthesis methods: Not applicable
Background
Diagnostic accuracy studies (DAS) are conducted to evaluate the efficacy of tests diagnosing a target disorder, such as diabetic retinopathy. DAS enables a clinician to make decisions regarding the potential utility of a test. However, if these accuracy studies are improperly conducted or incompletely reported, they may be prone to bias which may lead to ‘overly optimistic estimations of the diagnostic value of a test… exaggerated results may lead to premature adoption of new and more expensive tests’.
Tests used to screen for diabetic retinopathy are diverse and authors note that there is a lack of transparency in reports of DAS for diabetic retinopathy screening.
In 2003, the Standards for Reporting of Diagnostic Accuracy (STARD) statement was published to improve the quality of reporting of DAS and help authors clearly report the methodology.
Research objectives
‘To evaluate the quality of reporting of diagnostic accuracy studies in DR screening’.
Main findings
The authors identified 76 papers for inclusion in the review, all of which reported the diagnostic accuracy of tests for diabetic retinopathy screening (diagnostic accuracy studies).
Only 11.8% (nine out of 76) of manuscripts completely reported at least 50% of the STARD items. Descriptions of key aspects of the methodology were frequently missing. Only 8% (six out of 76) of the manuscripts had a flowchart describing the flow of participants within a study.
Based on the diagnostic accuracy studies included authors concluded that the quality of reporting of diagnostic accuracy studies for diabetic retinopathy screening was sub-optimal.
Authors suggested that the adherence to STARD guidelines may improve the quality of reporting of DR screening studies. Authors noted that only two of the top ten journals (British Medical Journal and British Journal of Ophthalmology) encouraged authors to use the STARD statement.
Methodology
Authors conducted a systematic literature survey in which a highly sensitive MEDLINE search was performed to identify reports of diagnostic accuracy or diabetic retinopathy screening studies published between 1995 and 2006. Only studies written in English were included in the review. Two reviewers independently assessed the titles and abstracts for potential inclusion. Selected papers were then independently assessed for inclusion by two investigators.
The STARD checklist was used to evaluate the quality of reporting of each publication. Authors noted that this study looked only at the quality of reporting and not the methodological quality of the included studies, which was outside the remit of this review.
Applicability/external validity
The authors did not specifically address the applicability of the results, but they did suggest that adherence to STARD guidelines would improve the quality of reporting of test accuracy studies in general.
Geographic focus
Authors do not report the geographical focus of the studies included in the review.
Quality assessment
Medium confidence was attributed to the conclusions about the effects of this review as limitations were identified. The authors used appropriate methods to reduce risk of bias in terms of independent screening and data extraction of included studies. However, this review had limitations in the search for literature. Authors did not report contacting authors/experts or reviewing reference lists in included studies as part of the search strategy.
The STARD checklist was used to evaluate the quality of reporting of each publication. Authors noted that this study looked only at the quality of reporting and not the methodological quality of the included studies, which was outside the remit of this review.
The review was useful in highlighting the need for researchers to adhere to the STARD guidelines to improve the quality of reporting of diagnostic accuracy studies in diabetic retinopathy screening.
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.